-
Copy-number signatures and mutational processes in ovarian carcinoma
Study
EGAS00001002557
-
Sequencing_melanoma_germlines
Study
EGAS00001002081
-
Exome-wide somatic mutation characterization of small bowel adenocarcinoma
Study
EGAS00001002559
-
Comparative genomics research for Chinese colorectal cancer
Study
EGAS00001002576
-
Roma Sequencing Study
Study
EGAS00001004287
-
Inhibiton of the GABPB1L-containing GABP tetramer is sufficient to reverse replicative immortality in TERT promoter mutant glioblastoma cells.
Study
EGAS00001002582
-
Systematic kinase inhibitor profiling identifies CDK9 as a synthetic lethal target in NUT midline carcinoma
Study
EGAS00001002588
-
The exomic landscape of t(14,18) negative diffuse follicular lymphoma with 1p36 deletion
Study
EGAS00001002594
-
Whole Genomes Define Concordance in Matched Primary, Xenograft, and Organoid Models of Pancreas Cancer
Study
EGAS00001002597
-
The genomic landscape of cutaneous squamous cell carcinoma from immunosuppressed and immunocompetent patients reveals common drivers and a novel mutational signature associated with chronic azathioprine exposure
Study
EGAS00001002612
-
The_Transcriptome_of_PLX4032_resistance
Study
EGAS00001000413
-
Identification of a Fumarate-Hydratase Deficient-like RCC Subtype with Convergent Pathway Alterations
Study
EGAS00001002646
-
Detection of clinically relevant genetic and transcriptomic landscape in DLBCL uniformly treated by R-CHOP
Study
EGAS00001002657
-
Discovery_of_resistance_mechanisms_to_the_BRAF_inhibitor_vemurafenib_in_metastatic_BRAF_mutant_melanoma
Study
EGAS00001000812
-
WGS of 32 paired SRCC samples
Study
EGAS00001002668
-
Identification_of_drug_resistance_genes_in_melanoma_by_mRNA_gene_expression
Study
EGAS00001000815
-
Identification_of_drug_resistance_genes_in_melanoma_by_small_RNAs_expression_analysis
Study
EGAS00001000816
-
Therapeutic Targeting of Ependymoma as Informed by Oncogenic Enhancer Profiling
Study
EGAS00001002696
-
Primary_angiosarcoma_Whole_Genome_Sequencing
Study
EGAS00001000851
-
Whole exome sequencing of cell-free DNA reveals temporo-spatial heterogeneity and identifies treatment-resistant clones in neuroblastoma
Study
EGAS00001002705
-
Sequencing-based counting and size profiling of plasma Epstein-Barr virus DNA enhance population screening of nasopharyngeal carcinoma.
Study
EGAS00001002707
-
Comprehensive genomic profiling of matched glioblastoma tumours, cell-lines, and xenografts reveals genomic stability and adaptation to disparate growth environments
Study
EGAS00001002709
-
MutWP1__CRUK_Grand_Challenge_Mutographs_of_Cancer__Oesophageal_squamous_cell_carcinoma
Study
EGAS00001002725
-
MutWP1__CRUK_Grand_Challenge_Mutographs_of_Cancer__pancreas
Study
EGAS00001002726
-
UK10K RARE COLOBOMA
Study
EGAS00001000127